Aethlon Medical, Inc.
AEMD
$0.58
-$0.02-2.63%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -21.92% | -31.43% | -38.77% | -28.15% | -26.07% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -21.92% | -31.43% | -38.77% | -28.15% | -26.07% |
| Operating Income | 21.92% | 31.43% | 38.77% | 28.15% | 26.07% |
| Income Before Tax | 46.58% | -20.54% | 0.10% | -9.40% | -9.66% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 46.58% | -20.54% | 0.10% | -9.40% | -9.66% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 46.58% | -20.54% | 0.10% | -9.40% | -9.66% |
| EBIT | 21.92% | 31.43% | 38.77% | 28.15% | 26.07% |
| EBITDA | 22.57% | 32.33% | 39.81% | 28.86% | 26.68% |
| EPS Basic | 81.66% | 61.60% | 75.13% | 77.69% | 77.40% |
| Normalized Basic EPS | 81.72% | 68.28% | 75.05% | 77.61% | 77.33% |
| EPS Diluted | 81.66% | 61.60% | 75.13% | 77.69% | 77.40% |
| Normalized Diluted EPS | 81.72% | 68.28% | 75.05% | 77.61% | 77.33% |
| Average Basic Shares Outstanding | 331.15% | 239.23% | 189.93% | 291.77% | 396.58% |
| Average Diluted Shares Outstanding | 331.15% | 239.23% | 189.93% | 291.77% | 396.58% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |